Nimbus Therapeutics, formerly Nimbus Discovery, is a drug development company that focuses on metabolic diseases, cancer, and immune-inflammatory disorders. It combines computational technologies and machine learning-based predictive modeling approaches to progress small molecules through discovery and development. Its advanced programs include ACC, IRAK4, and Tyk2.